ODX.L Regulatory News (ODX)

Omega Diagnostics Group PLC

("Omega" or the "Company")

Allersys® CE-Mark

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked two additional allergens, extending the menu to 53 allergens which can be run on the fully automated IDS Instrument.

These allergens will be supplied to IDS under the global distribution agreement announced on 20 April 2018. Ongoing investment to increase the menu is supported by the research and development grant of up to £1.8 million, which the Company secured from Scottish Enterprise in August 2016.

Contacts: